Deutsche Bank’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-74,425
Closed -$764K 3926
2023
Q2
$764K Buy
+74,425
New +$759K ﹤0.01% 2128

Deutsche Bank's DALS Position: Q3 2023 in Review

Deutsche Bank sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 74,425 shares — an estimated $764K sold.

Deutsche Bank first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $764K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Deutsche Bank reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Deutsche Bank sold 74,425 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $764K.
  • Deutsche Bank first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2023 and held it in 1 quarter.
  • Deutsche Bank's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $764K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.